Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Imatinib Mesylate × Sarcoma × Clear all

Status

Completed 68 Terminated 11 Unknown 9 Recruiting 8 Active not recruiting 4 Withdrawn 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

tazemetostat 2 regorafenib 2 Trabectedin 2 omburtamab I-131 1 nirogacestat 1 ganitumab 1 fludarabine phosphate 1 avapritinib 1 Whole-Body Irradiation 1 Tacrolimus 1 TH 302 1 Mycophenolic Acid 1 Imatinib Mesylate 1 Everolimus 1 DOXO-EMCH 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01613053 2015-04-24

MACS2226

Novartis

No longer available

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡